C000219007 Performance — Fidelity Disruptive Medicine Fund, Loyalty Class 2
Data updated: 2023-08-03
C000219007 returned −7.35% over one year to Feb 2023. Over one year the fund beat its International Thematic Equity category average: $100 grew to $93, against $86 for the category. Volatility over the past 12 months was 20.86% a year. In the 12 months to May 2023 the fund lost a net $13.8M, and assets reached $43.22M.
C000219007 Growth of $100
What $100 invested in Fidelity Disruptive Medicine Fund grew to, compounded from monthly returns reported on SEC Form N-PORT, against the International Thematic Equity category average over the same months.
| Period | C000219007 | Category average |
|---|---|---|
| 1 year (Mar 2022 – Feb 2023) | $93 | $86 |
| Since data start (May 2020 – Feb 2023) | $107 | $117 |
C000219007 Trailing Returns
Total returns to Feb 2023, from SEC N-PORT.
| Period | Total return |
|---|---|
| 1 year | −7.35% |
| 3 years (annualised) | +2.44% |
C000219007 Annual Returns
Calendar-year total returns of Fidelity Disruptive Medicine Fund, compounded from monthly SEC N-PORT returns. Partial years show the months covered.
| Year | Total return |
|---|---|
| 2023 (Jan–Feb) | −0.47% |
| 2022 | −21.37% |
| 2021 | +11.63% |
| 2020 (May–Dec) | +22.56% |
C000219007 Monthly Returns
Monthly total returns as reported on SEC Form N-PORT.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023 | +4.4% | −4.7% | — | — | — | — | — | — | — | — | — | — |
| 2022 | −14.7% | −0.9% | +2.6% | −12.6% | −4.3% | +0.2% | +8.8% | −1.9% | −4.9% | +5.6% | +5.1% | −3.8% |
| 2021 | +1.8% | −0.3% | −1.4% | +6.7% | −2.5% | +5.1% | +1.7% | +3.3% | −3.7% | +5.4% | −6.9% | +2.7% |
| 2020 | — | — | — | — | +7.2% | +1.3% | +4.6% | +1.2% | −0.5% | −1.9% | +4.9% | +4.2% |
C000219007 Risk
Risk measures from monthly returns over Mar 2022 – Feb 2023.
- 1-year volatility (annualised): 20.86%
- Best month: +8.76% (Jul 2022)
- Worst month: −12.59% (Apr 2022)
C000219007 Fund Flows
Monthly money in and out of Fidelity Disruptive Medicine Fund, from SEC Form N-PORT.
- 12-month net flow: −$13.8M
- 12-month gross sales (incl. reinvestments): $54.7M
- Sales ÷ redemptions: 0.80×
| Month | Sales | Redemptions | Net flow |
|---|---|---|---|
| May 2023 | $41.3M | $41.6M | −$371K |
| Apr 2023 | $2.1M | $817K | $1.3M |
| Mar 2023 | $589K | $1.5M | −$877K |
| Feb 2023 | $500K | $1.4M | −$892K |
| Jan 2023 | $684K | $1.6M | −$912K |
| Dec 2022 | $680K | $3.5M | −$2.8M |
| Nov 2022 | $867K | $1.5M | −$592K |
| Oct 2022 | $760K | $8.1M | −$7.4M |
| Sep 2022 | $751K | $2.0M | −$1.3M |
| Aug 2022 | $2.2M | $2.6M | −$378K |
| Jul 2022 | $2.7M | $1.8M | $937K |
| Jun 2022 | $1.5M | $2.2M | −$629K |
C000219007 Assets Under Management
Net assets of Fidelity Disruptive Medicine Fund by report date, from SEC N-PORT filings.
| Report date | Net assets |
|---|---|
| 2023-05-31 | $43.22M |
| 2023-02-28 | $42.07M |
| 2022-11-30 | $48.64M |
| 2022-08-31 | $55.82M |
| 2022-05-31 | $52.35M |
| 2022-02-28 | $66.94M |
| 2021-11-30 | $80.33M |
| 2021-08-31 | $82.18M |
| 2021-05-31 | $68.18M |
| 2021-02-28 | $63.60M |
| 2020-11-30 | $41.69M |
| 2020-08-31 | $26.20M |
For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.